StonvexLoading…
StonvexStonvexStonvexCore line items from TAC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | C$2.40B | C$2.85B | C$3.35B | C$2.98B |
Operating Income | C$140.00M | C$585.00M | C$1.09B | C$531.00M |
Net Income | C$-158.00M | C$239.00M | C$796.00M | C$161.00M |
EPS (Diluted) | C$-0.64 | C$0.59 | C$2.33 | C$0.01 |
Total Assets | C$8.66B | C$9.50B | C$8.66B | C$10.74B |
Total Liabilities | C$7.20B | C$7.66B | Not available | Not available |
Cash & Equivalents | C$205.00M | C$337.00M | C$348.00M | C$1.13B |
Free Cash Flow OCF − CapEx | C$397.00M | C$485.00M | C$589.00M | C$-41.00M |
Shares Outstanding | Not available | Not available | Not available | Not available |